PD0325901 (Mirdametinib) is a potent, selective MEK1/2 inhibitor. It affects the MAPK/ERK signaling pathway by preventing ERK1/2 phosphorylation, effectively inhibiting cancer cell proliferation, migration, and inflammation, while promoting stem cell pluripotency.
PD0325901 (Mirdametinib) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for PD0325901 (Mirdametinib) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.